Last reviewed · How we verify

Administration of quetiapine XR

Tri-Service General Hospital · Phase 3 active Small molecule

Administration of quetiapine XR is a Atypical antipsychotic Small molecule drug developed by Tri-Service General Hospital. It is currently in Phase 3 development for Schizophrenia, Bipolar I disorder (acute manic or mixed episodes), Bipolar depression.

Quetiapine is an atypical antipsychotic that antagonizes dopamine D2 and serotonin 5-HT2A receptors in the brain.

Quetiapine is an atypical antipsychotic that antagonizes dopamine D2 and serotonin 5-HT2A receptors in the brain. Used for Schizophrenia, Bipolar I disorder (acute manic or mixed episodes), Bipolar depression.

At a glance

Generic nameAdministration of quetiapine XR
SponsorTri-Service General Hospital
Drug classAtypical antipsychotic
TargetDopamine D2 receptor, Serotonin 5-HT2A receptor
ModalitySmall molecule
Therapeutic areaPsychiatry
PhasePhase 3

Mechanism of action

Quetiapine blocks dopamine and serotonin receptors, reducing abnormal neurotransmitter activity associated with psychotic symptoms and mood disturbances. The extended-release (XR) formulation provides sustained drug delivery over 24 hours, improving medication adherence and maintaining steady-state plasma concentrations.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Administration of quetiapine XR

What is Administration of quetiapine XR?

Administration of quetiapine XR is a Atypical antipsychotic drug developed by Tri-Service General Hospital, indicated for Schizophrenia, Bipolar I disorder (acute manic or mixed episodes), Bipolar depression.

How does Administration of quetiapine XR work?

Quetiapine is an atypical antipsychotic that antagonizes dopamine D2 and serotonin 5-HT2A receptors in the brain.

What is Administration of quetiapine XR used for?

Administration of quetiapine XR is indicated for Schizophrenia, Bipolar I disorder (acute manic or mixed episodes), Bipolar depression, Adjunctive treatment of major depressive disorder.

Who makes Administration of quetiapine XR?

Administration of quetiapine XR is developed by Tri-Service General Hospital (see full Tri-Service General Hospital pipeline at /company/tri-service-general-hospital).

What drug class is Administration of quetiapine XR in?

Administration of quetiapine XR belongs to the Atypical antipsychotic class. See all Atypical antipsychotic drugs at /class/atypical-antipsychotic.

What development phase is Administration of quetiapine XR in?

Administration of quetiapine XR is in Phase 3.

What are the side effects of Administration of quetiapine XR?

Common side effects of Administration of quetiapine XR include Somnolence/sedation, Dry mouth, Dizziness, Weight gain, Headache, Constipation.

What does Administration of quetiapine XR target?

Administration of quetiapine XR targets Dopamine D2 receptor, Serotonin 5-HT2A receptor and is a Atypical antipsychotic.

Related